Cardiac troponin T elevation predicts mortality in hospitalized COVID-19 patients

Katelyn A Bruno1,2, R Scott Wright3, Joshua Culberson1,2

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States of America.

Insights

High-sensitivity cardiac troponin T (hs-cTnT) levels predict mortality in hospitalized COVID-19 patients. This prognostic ability holds true for both males and females, irrespective of age.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biomarkers

Background:

  • COVID-19 can cause cardiac injury, impacting patient outcomes.
  • Cardiac troponins are key biomarkers for myocardial damage.

Purpose of the Study:

  • To determine if cardiac troponin T (hs-cTnT) levels predict mortality in hospitalized COVID-19 patients.
  • To assess this prognostic ability across diverse demographics including sex and age.

Main Methods:

  • Analysis of hs-cTnT levels in 1050 severely ill COVID-19 patients.
  • Data collected during the first wave of the pandemic (April-August 2020).
  • Inclusion of patients from the Expanded Access Program for convalescent plasma study.

Main Results:

  • A continuous relationship was observed between hs-cTnT levels and mortality.
  • This association was consistent across both male and female patients.
  • The prognostic value of hs-cTnT was independent of patient age.

Conclusions:

  • hs-cTnT is a valuable prognostic biomarker for predicting mortality in hospitalized COVID-19 patients.
  • The predictive capability of hs-cTnT extends across all relevant patient groups.
  • Clinical Trials registration number: NCT04338360.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
194
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
700
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
155
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
235